A citation-based method for searching scientific literature

Maria E Cabanillas, David G McFadden, Cosimo Durante. Lancet 2016
Times Cited: 647







List of co-cited articles
366 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
37


Thyroid cancer.
Tobias Carling, Robert Udelsman. Annu Rev Med 2014
187
9


Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
974
9

Current thyroid cancer trends in the United States.
Louise Davies, H Gilbert Welch. JAMA Otolaryngol Head Neck Surg 2014
8

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger,[...]. Thyroid 2009
7

Molecular genetics and diagnosis of thyroid cancer.
Yuri E Nikiforov, Marina N Nikiforova. Nat Rev Endocrinol 2011
615
7

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
7

The changing incidence of thyroid cancer.
Cari M Kitahara, Julie A Sosa. Nat Rev Endocrinol 2016
481
7

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
574
6

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
6

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
6

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
Eleonora Molinaro, Cristina Romei, Agnese Biagini, Elena Sabini, Laura Agate, Salvatore Mazzeo, Gabriele Materazzi, Stefano Sellari-Franceschini, Alessandro Ribechini, Liborio Torregrossa,[...]. Nat Rev Endocrinol 2017
211
6

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
5

Novel treatments for anaplastic thyroid carcinoma.
Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Ilaria Ruffilli, Concettina La Motta, Sabrina Rosaria Paparo, Armando Patrizio, Roberto Vita, Salvatore Benvenga, Gabriele Materazzi,[...]. Gland Surg 2020
40
12

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
5

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong,[...]. Lancet 2014
877
5

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
5

Heterogeneity of Thyroid Cancer.
Ewa Chmielik, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Michal Jarzab, Jolanta Krajewska, Agnieszka Czarniecka, Barbara Jarzab. Pathobiology 2018
63
7

Evolving Understanding of the Epidemiology of Thyroid Cancer.
Carolyn Dacey Seib, Julie Ann Sosa. Endocrinol Metab Clin North Am 2019
143
5

Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
Joseph J Wiltshire, Thomas M Drake, Lesley Uttley, Sabapathy P Balasubramanian. Thyroid 2016
182
5

Papillary thyroid cancer: time course of recurrences during postsurgery surveillance.
Cosimo Durante, Teresa Montesano, Massimo Torlontano, Marco Attard, Fabio Monzani, Salvatore Tumino, Giuseppe Costante, Domenico Meringolo, Rocco Bruno, Fabiana Trulli,[...]. J Clin Endocrinol Metab 2013
196
4

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Jae Yong Cho, Jan H M Schellens, Jean Charles Soria, Patrick Y Wen, Christoph Zielinski, Maria E Cabanillas, Gladys Urbanowitz,[...]. J Clin Oncol 2018
385
4

Targeted Therapy in Thyroid Cancer: State of the Art.
L Valerio, L Pieruzzi, C Giani, L Agate, V Bottici, L Lorusso, V Cappagli, L Puleo, A Matrone, D Viola,[...]. Clin Oncol (R Coll Radiol) 2017
72
5

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
289
4

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
Zhi Liu, Peng Hou, Meiju Ji, Haixia Guan, Kimberly Studeman, Kirk Jensen, Vasily Vasko, Adel K El-Naggar, Mingzhao Xing. J Clin Endocrinol Metab 2008
289
4

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
4

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
C Durante, N Haddy, E Baudin, S Leboulleux, D Hartl, J P Travagli, B Caillou, M Ricard, J D Lumbroso, F De Vathaire,[...]. J Clin Endocrinol Metab 2006
951
4

Progress in molecular-based management of differentiated thyroid cancer.
Mingzhao Xing, Bryan R Haugen, Martin Schlumberger. Lancet 2013
361
4

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
Alan L Ho, Ravinder K Grewal, Rebecca Leboeuf, Eric J Sherman, David G Pfister, Desiree Deandreis, Keith S Pentlow, Pat B Zanzonico, Sofia Haque, Somali Gavane,[...]. N Engl J Med 2013
483
4

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Stephanie Davis, Jena D French, Pierre Vanden Borre, Daniel V LaBarbera, Aik-Choon Tan,[...]. Clin Cancer Res 2018
217
4

Papillary thyroid carcinoma: an update.
Virginia A LiVolsi. Mod Pathol 2011
176
4

Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
Salvatore Vaccarella, Silvia Franceschi, Freddie Bray, Christopher P Wild, Martyn Plummer, Luigino Dal Maso. N Engl J Med 2016
553
4

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.
Loredana Lorusso, Virginia Cappagli, Laura Valerio, Carlotta Giani, David Viola, Luciana Puleo, Carla Gambale, Elisa Minaldi, Maria Cristina Campopiano, Antonio Matrone,[...]. Int J Mol Sci 2021
17
23

Geographic influences in the global rise of thyroid cancer.
Jina Kim, Jessica E Gosnell, Sanziana A Roman. Nat Rev Endocrinol 2020
137
4

The Current Histologic Classification of Thyroid Cancer.
Sylvia L Asa. Endocrinol Metab Clin North Am 2019
42
9

Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.
Silvia Martina Ferrari, Poupak Fallahi, Maria Rosaria Galdiero, Ilaria Ruffilli, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Armando Patrizio, Valeria Mazzi, Gilda Varricchi,[...]. Int J Mol Sci 2019
90
4

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
431
4

The Diagnosis and Management of Thyroid Nodules: A Review.
Cosimo Durante, Giorgio Grani, Livia Lamartina, Sebastiano Filetti, Susan J Mandel, David S Cooper. JAMA 2018
250
4

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Feng-Hsuan Liu, Sheng-Fong Kuo, Chuen Hsueh, Tzu-Chieh Chao, Jen-Der Lin. J Surg Oncol 2015
80
5

Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
104
4

2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Keith C Bible, Electron Kebebew, James Brierley, Juan P Brito, Maria E Cabanillas, Thomas J Clark, Antonio Di Cristofano, Robert Foote, Thomas Giordano, Jan Kasperbauer,[...]. Thyroid 2021
90
4

Understanding the ever-changing incidence of thyroid cancer.
Cari M Kitahara, Julie A Sosa. Nat Rev Endocrinol 2020
38
10

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Mahul B Amin, Frederick L Greene, Stephen B Edge, Carolyn C Compton, Jeffrey E Gershenwald, Robert K Brookland, Laura Meyer, Donna M Gress, David R Byrd, David P Winchester. CA Cancer J Clin 2017
4

Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.
Mardiaty Iryani Abdullah, Sarni Mat Junit, Khoon Leong Ng, Jaime Jacqueline Jayapalan, Barani Karikalan, Onn Haji Hashim. Int J Med Sci 2019
105
4

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.
Jennifer R Wang, Mark E Zafereo, Ramona Dadu, Renata Ferrarotto, Naifa L Busaidy, Charles Lu, Salmaan Ahmed, Maria K Gule-Monroe, Michelle D Williams, Erich M Sturgis,[...]. Thyroid 2019
85
3

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.
Robert C Smallridge, Laura A Marlow, John A Copland. Endocr Relat Cancer 2009
276
3

Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
Eric J Sherman, Lara A Dunn, Alan L Ho, Shrujal S Baxi, Ronald A Ghossein, Matthew G Fury, Sofia Haque, Cami S Sima, Grace Cullen, James A Fagin,[...]. Cancer 2017
44
6

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
Steven I Sherman, Douglas O Clary, Rossella Elisei, Martin J Schlumberger, Ezra E W Cohen, Patrick Schöffski, Lori J Wirth, Milan Mangeshkar, Dana T Aftab, Marcia S Brose. Cancer 2016
57
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.